Can AI cut drug screening costs by 95%?.Our latest paper with @Ryvu_Therap and co-authors shows how image-based HTS on patient-derived CRC models becomes scalable. Read more: 📖 #AIinBiotech #DrugDiscovery

A surgical robot, trained on 17 hours of video, just performed a gallbladder removal with 100% success - fully autonomously. Developed at Johns Hopkins, this system marks a new milestone in AI-assisted surgery. Source:

Can we predict how every cancer cell responds to therapy - before testing in the lab?. A new Helmholtz–Sanger–Parse alliance is building a Cancer Plasticity Atlas with organoids, single-cell data, and AI to map treatment response.

What if we could treat disease without a predefined target?. Phenotypic-first strategies - once limited by toolsets - are now increasingly adopted, thanks to omics, modeling, and platforms like PhenAID. Explore how it's reshaping translational research:

A drug discovered by AI just reached human trials. Rentosertib, for pulmonary fibrosis, showed it’s safe with early signs it could work. It’s a small step for the drug, but a big moment for how AI could shape future medicines. #DrugDiscovery

Drug discovery isn’t just science anymore - it’s a data challenge. Read the full recap from #DiscoveryEurope2025 . #AIinBiotech #DrugDiscovery #DigitalBiology #ArdigenNews

Top AI in Biotech Market Stories series: .Can AI simulate how a cell responds before you run the experiment? GSK’s new LPM model says: yes. It predicts perturbation effects across genes, drugs & assays — both morphology & transcriptomics.

💡 AI News. Microsoft & partners introduce EvAgg - a new AI system that helps clinicians make faster decisions when every minute counts. Powered by LLMs. Now open-source and integrated with seqr. 🔗 📄

We’re in Basel for #DiscoveryEurope2025 – 2 days of insights, challenges, and practical thinking in drug discovery: from AI in R&D to neurodegeneration, RNA delivery, and data strategy. We're here to share, learn, and connect. Let’s catch up. #DrugDiscovery #AIinPharma

Don't miss this!.Join Kamil Malisz (Ardigen) & Hassan Sirelkhatim (NVIDIA) to see how GPU acceleration is transforming biomedical data analysis. 📅 June 24 | 🕔 5 PM CEST.Register: #bioinformatics #GPU

AI at #BIO2025 wasn’t just hype - it was about outcomes. 🔹 ROI = data + biology.🔹 Ethical AI = inclusive by design.🔹 Regulators = catching up fast.We break it all down in our latest blog post → #BIO2025 #Biotech #LifeSciences.

What’s next after monoclonal antibodies?. Biologics are evolving - think bispecifics, ADCs, fusion proteins, and therapies tailored to the individual. AI and multi-omics are pushing the boundaries even further. Read more:. 🔗

We're at the Genomics England Research Summit 2025!. Our Bioinformatics Director, Marek Kudła, shares how LLMs + knowledge graphs can unlock GWAS data for drug discovery. Thanks @GenomicsEngland for the space to connect!. See you at the London Biotech Show!.#GenomicsSummit2025

Your prototype works on test data. But what happens at petabyte scale?. In our new blog:. - How GPU acceleration transforms omics workflows. - Why cloud costs spiral without the right setup. - What it takes to go from prototype to production. Read now:

Nabla Bio designed the first antibody activators for CXCR7 using JAM, an AI model boosting success by 70x - no retraining, no wet lab. A major step in GPCR targeting. 🔗 P.S. Our AI in biotech recap is here:

From prototype to production – faster, smarter, cheaper. Join @Ardigen & @nvidia for a 45-min deep dive into scaling biomedical data analysis with GPUs. Date: June 24 | Free to attend.Time: 5:00 PM CEST / 11:00 AM ET. #Biotech #Nextflow #Bioinformatics

Join us at #BIO2025 in Boston, June 16–19. Let’s connect and explore how we can collaborate. 📍 Booth #2682 – we look forward to meeting you. Register here: #Biotech #LifeSciences

Stuck in slow bioinformatics workflows?. Join our free webinar with experts from Ardigen & NVIDIA to learn how GPU acceleration turns prototypes into production-ready engines. When: 24th of June.Time: 5:00 pm CEST. Register now: #Bioinformatics #webinar

Think AI will solve your R&D problems? Think again. Smart biotech teams ask:. - Where does AI truly help?. - Where does it fall short?. - How do we keep science real?. JanMajta shares 10 years of insights. Read more: #AIinBiotech #DrugDiscovery

By June 30, the FDA rolls out AI to speed up drug approvals.Faster reviews, fewer delays, safer access to treatments. A global shift in how we regulate innovation. #AI #HealthTech #FDA